Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
2017_Winter_CMTA_Report
CMTA_2020_Annual_Report
2020_Spring_CMTA_Report
CMT Awareness Month 2022
…the clinical and research communities. CMT Awareness Week was born in September 2010, as the CMTA community began to educate others about CMT. Over the years, one special week morphed…
CMTA’s New Video Aims to Increase Awareness About CMT
…build support for the CMT community. Together, we can make a difference! For more information about Charcot-Marie-Tooth disease (CMT), visit CMTA’s What is CMT webpage. Published on: January 23, 2025…
CMTA-STAR Alliance Partner NMD Pharma Announces FDA Orphan Drug Designation for NMD670
…SYNAPSE-CMT Phase 2 clinical trial, which began in November 2024. This study is investigating the effects of NMD670 for 80 adult patients with genetically confirmed CMT1 or CMT2 subtypes across…
Advancing the Understanding of CMT2A and CMT2F: A Call to Beat CMT
The Charcot-Marie-Tooth Association (CMTA), through its Strategy To Accelerate Research (STAR) initiative, is proud to support groundbreaking research that seeks to deepen our understanding of CMT2A and CMT2F, two axonal…
CMT1B Research
…CMT. Support CMT Research View the projects currently active or recently completed in the CMT1B drug development pipeline. CMT1B RESEARCH PROJECTS PROJECT GOAL: IMPROVE THE PROTEASOME FUNCTION TO TREAT CMT1B…
Repurposing Drugs for CMT1A: An Encouraging Approach
…project underscores CMTA’s commitment to supporting cutting-edge research and fostering collaboration between the CMT community, clinicians, and industry experts. CMTA’s Strategy To Accelerate Research (STAR) initiatives continue to be vital…
Características y Síntomas de la CMT
Características y Síntomas de la CMT Aunque hay muchas diferentes causas genéticas de la CMT, todo tipo tienden a tener síntomas muy similares. Lo que sigue es una descripción general…